Neovasc (TSE:NVCN) Stock Price Up 7.8%

Shares of Neovasc Inc. (TSE:NVCNGet Rating) rose 7.8% during mid-day trading on Tuesday . The stock traded as high as C$25.00 and last traded at C$24.80. Approximately 762 shares were traded during trading, a decline of 66% from the average daily volume of 2,211 shares. The stock had previously closed at C$23.00.

Neovasc Price Performance

The company has a current ratio of 8.44, a quick ratio of 8.04 and a debt-to-equity ratio of 44.86. The stock has a market capitalization of C$68.13 million and a PE ratio of -1.57. The business has a fifty day moving average price of C$13.88 and a 200-day moving average price of C$10.63.

About Neovasc

(Get Rating)

Neovasc Inc, a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina.

Featured Stories

Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.